Amarin’s lead product, VASCEPA, is a prescription drug. In the United States, VASCEPA is approved and marketed by Amarin’s commercial team for two indications: one for treatment of patients with very high triglyceride levels, and one for cardiovascular risk reduction in addition to medications such as statins in high-risk patients. More @Wikipedia
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.